Spotlight: Off-the-shelf only works if the system can absorb it: What delivery, partnerships, and hospital readiness must look like next

Hospitals are the bottleneck and the solution: Why even off-the-shelf cell therapies fail without hospital integration and what practical delivery models are emerging across Europe.

Designing delivery pathways early: How partnerships between developers, hospitals, and service providers can reduce friction from trial delivery through to routine use.

What scalable access really requires: The operational capabilities that must be in place before approval if therapies are to move beyond centres of excellence.